EFFICIENT AND ETHICAL RESPONSE-ADAPTIVE RANDOMIZATION DESIGNS FOR MULTI-ARM CLINICAL TRIALS WITH WEIBULL TIME-TO-EVENT OUTCOMES

被引:13
|
作者
Sverdlov, Oleksandr [1 ]
Ryeznik, Yevgen [2 ]
Wong, Weng-Kee [3 ]
机构
[1] Novartis Pharmaceut, Translat Sci, E Hanover, NJ 07936 USA
[2] CS Ltd, Kharkov, Ukraine
[3] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA USA
关键词
Censoring; D-optimal design; Ethical concern; Response-adaptive randomization; Weibull distribution; BIASED COIN DESIGNS; OPTIMAL ALLOCATION;
D O I
10.1080/10543406.2014.903261
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We consider a design problem for a clinical trial with multiple treatment arms and time-to-event primary outcomes that are modeled using the Weibull family of distributions. The D-optimal design for the most precise estimation of model parameters is derived, along with compound optimal allocation designs that provide targeted efficiencies for various estimation problems and ethical considerations. The proposed optimal allocation designs are studied theoretically and are implemented using response-adaptive randomization for a clinical trial with censored Weibull outcomes. We compare the merits of our multiple-objective response-adaptive designs with traditional randomization designs and show that our designs are more flexible, realistic, generally more ethical, and frequently provide higher efficiencies for estimating different sets of parameters.
引用
收藏
页码:732 / 754
页数:23
相关论文
共 50 条